Quercetin induces p53-independent apoptosis in human prostate cancer cells by modulating Bcl-2-related proteins: A possible mediation by IGFBP-3

Oncology Research

Volumn 16, Issue 2, 2006, Pages 67-74

  Vijayababu, Marati R ^a   Kanagaraj, P ^a   Arunkumar, A ^a   Ilangovan, R ^a   Dharmarajan, A ^b   Arunakaran, J ^a  

^a UNIVERSITY OF MADRAS   (India)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Apoptosis; Bcl 2 protein; Insulin like growth factor binding protein 3 (IGFBP 3); Quercetin

Indexed keywords

DNA FRAGMENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; QUERCETIN; SOMATOMEDIN BINDING PROTEIN 3;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 33745699694     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783981224     Document Type: Article

References (33)

1. Kefford, J. F. Citrus fruits and processed citrus products in human nutrition. World Rev. Nutr. Diet 6:197-249; 1996.
2. Yoshida, M.; Yarnmoto, M.; Nikaido, T. Quercetin arrest leukemic T-cells in late G1 phase of the cell cycle. Cancer Res. 52:6676-6681; 1992.
3. Csokay, B.; Prajda, N.; Weber, G.; Olah, E. Molecular mechanisms in the antiproliferative action of quercetin. Life Sci. 60:2157-2163; 1997.
4. Wang, S.; DeGroff, V. L.; Clinton, S. K. Tomato and soy polyphenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase. J. Nutr. 133:2367-2376; 2003.
5. Vijayababu, M. R.; Kanagaraj, P.; Arunkumar, A.; Aruldhas, M. M.; Arunakaran, J. Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. J. Cancer Res. Clin. Oncol. 28:765-771; 2005.
6. De Mellow, J. S.; Baxter, R. C. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem. Biophys. Res. Commun. 156:199-204; 1988.
7. Conover, C. A. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: Studies of underlying mechanism. Endocrinology 130:3191-3199; 1992.
8. Butt, A. J.; Firth, S. M.; Baxter, R. C. The IGF axis and programmed cell death. Immunol. Cell Biol. 77:256-262; 1999.
9. Chen, S. H.; Zanagnolo, V.; Preutthipan, S.; Roberts, K.; Goodman, S. B.; Dharmarajan, A. M. Role of Insulin-like growth factor-I in progesterone production and cell death in the rabbit corpus luteum. Endocrine 6:73-77; 1997.
10. Kaicer, E.; Blat, C.; Harel, L. IGF-I and IGF-binding proteins: stimulatory and inhibitory factors secreted by human prostatic adenocarcinoma cells. Growth Factors 4: 231-237; 1991.
11. Rajah, R.; Khare, A.; Lee, P. D.; Cohen, P. Insulin-like growth factor-binding protein-3 is partially responsible for high-serum-induced apoptosis in PC-3 prostate cancer cells. J. Endocrinol. 163:487-494; 1999.
12. Hong, J.; Zhang, G.; Dong, F.; Rechler, M. M. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J. Biol. Chem. 277:10489-10497; 2002.
13. Valentinis, B.; Bhala, A.; DeAngelis, T.; Baserga, R.; Cohen, P. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol. Endocrinol. 9:361-367; 1995.
14. Rajah, R.; Lee, K. W.; Cohen, P. Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: Role of Bcl-2 phosphorylation. Cell Growth Differ. 13:163-171; 2002.
15. Rajah, R.; Valentinis, B.; Cohen, P. Insulin-like growth factor binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 272:12181-12188; 1997.
16. Angelloz-Nicoud, P.; Binoux, M. Autocrine regulation of cell proliferation by the insulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology 136: 5485-5492; 1995.
17. Oh, Y.; Muller, H. L.; Ng, L.; Rosenfeld, R. Transforming growth factor-β induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J. Biol. Chem. 270: 13589-13592; 1995.
18. Huynh, H.; Pollak, M.; Zhang, J. C. Regulation of insulin-like growth factor (IGF) I and IGF binding protein-3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25 (OH) 2D3 and its analog EB1089. Int. J. Oncol. 13:137-143; 1998.
19. Gill, Z. P.; Perks, C. M.; Newcomb, P. V.; Holly, J. M. P. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in an non-IGF- dependent manner. J. Biol. Chem. 272: 25602-25607; 1997.
20. Gucev, Z. S.; Oh, Y.; Kelley, K. M.; Rosenfeld, R. G. Insulin-like growth factor binding protein-3 mediates retinoic acid- and transforming growth factor β 2-induced growth inhibition in human breast cancer cells. Cancer Res. 56:1545-1550; 1996.
21. Rozen, F.; Zhang, J.; Pollak, M. Antiproliferative action of tumor necrosis factor-α on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. Int. J. Oncol. 13:865-869; 1998.
22. Buckbinder, L.; Talbott, R.; Velasco-Miguel, S.; Takenaka, I.; Faha, B.; Seizinger, R.; Kley, N. Induction of the growth inhibitor IGF-binding protein-3 by p53. Nature 377:646-649; 1995.
23. Bromfield, G. P.; Meng, A.; Warde, P.; Bristow, R. G. Cell death in irradiated prostate epithelial cells: Role of apoptotic and clonogenic cell kill. Prostate Cancer Prostatic Dis. 6:73-85; 2003.
24. Reed, J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124:1-6; 1994.
25. Li, X.; Marani, M.; Yu, J.; Nan, B.; Roth, J. A.; Kagawa, S.; Fang, B.; Denner, L.; Marcelli, M. Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer. Cancer Res. 61:186-191; 2001.
26. Catz, S. D.; Johnson, J. L. BCL-2 in prostate cancer: A minireview. Apoptosis 8:29-37; 2003.
27. Vijayababu, M. R.; Kanagaraj, P.; Arunkumar, A.; Srinivasan, N.; Aruldhas, M. M.; Arunakaran, J. Effects of quercetin on IGF system components in PC-3 cells. XXII symposium of the Society for Reproductive Biology and Comparative Endocrinology (SRBCE), Chennai, India; 2004:30-31.
28. Martin, J. L.; Pattison, S. L. Insulin-like growth factor binding protein-3 is regulated by dihydrotestosterone and stimulates deoxyribonucleic acid synthesis and cell proliferation in LNCaP prostate carcinoma cell. Endocrinology 141:2401-2409; 2000.
29. Lowry, O. H.; Rise Brough, N. J.; Farr, A. L.; Randall, R. J. Protein measurement with the Folin-phenol reagent. J. Biol. Chem. 193:265-270; 1951.
30. Baxter, R. C. Signalling pathways involved in antiproliferative effects of IGFBP-3: A review. Mol. Pathol. 54:145-148; 1997.
31. Singleton, J. R.; Dixit, V. M.; Feldman, E. L. Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J. Biol. Chem. 271:31791-31794; 1996.
32. Parrizas, M.; LeRoith, D. Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology 138: 1355-1358; 1997.
33. Zi, X.; Zhang, J.; Agarwal, R.; Pollak, M. Silibinin upregulates insulin-like growth factor-binding protein-3 expression and inhibits proliferation of androgen-independent prostate cancer cells. Cancer Res. 60:5617-5620; 2000.